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ABSTRACT
Ulcerative colitis (VC), a form of inflammatory bowel disease (IBD), is characterised
by chronic inflammation of the colon. Its pathogenesis is associated with abnormal
composition of the gut microflora. The use of probiotics, especially lactic acid
bacteria (LAB), to improve gut microflora could thus serve as a good strategy in
modulating inflammatory response during treatment of DC. As such, the principal aim
of the present study was to identify LAB with potential anti-inflammatory effects
against DC. For this purpose, 12 LAB isolated from Malaysian fermented food and
dairy products were screened for their inhibitory effects against nitric oxide (NO), a
known biomarker of DC using the Griess assay in vitro. The RAW 264.7
macrophages were cultured and served as the source of NO. Two LAB strains which
elicited the most potent anti-NO activity, Pediococcus pentosaceus (LAB 8) and
Lactobacillus plantarum (LAB 12), were then fermented in soymilk for validation of
their anti-inflammatory effect in vivo. Colitis was induced in BALB/c mice (n == 121
group) by administrating 30/0 DSS to drinking water for 7 days together with the LAB
(109 cfu/200 Ill). Lactobacillus casei strain Shirota (LABPC) and sulfasalazine were
used as reference strain and positive control, respectively. After 28 days of pre-
treatment with 8M-LAB followed by 7 days of colitis induction, colons were removed
for morphological examination before homogenised and being subjected to
examination of gene expression (iNOS and NOD2) and physiological responses
related to inflammation (NO, myeloperoxidase (MPO), lipid peroxidation and
cytokines [tumor necrosis factor-a (TNF-a), interferon-v (IFN-y), interleukin 17A (IL-
17A), interleukin 6 (IL-6), and interleukin 12 (IL-12)] levels). Preliminary in vitro
screening found LAB 8 and LAB 12 to exhibit significant (p<O.05) NO inhibitory
effect when compared to the rest of the LAB and the constitutive NO synthase (NOS)
inhibitor, N-nitro-L-arginine methyl ester (L-NAME) which served as positive control.
Subsequent in vivo study using mice with DSS-induced colitis continned the anti-
inflammatory effects of 8M-LAB8 and SM-LABI2. The ability of SM-LAB8 and
SM-LABI2 in reversing inflammation could be clearly observed morphologically
from the histological analysis. Even though all groups administered by SM-LAB
showed symptoms of less severe colitis as indicated by the percentage of weight loss,
colon length and DAI scoring, only SM-LAB 12 exhibited significant results (p<O.05).
Furthermore, SM-LABI2 was also significantly (p<O.05) reduced concentrations of
tested inflammatory markers which include NO, MPO, lipid peroxidation, TNF-a,
IFN-y, IL-6, IL-I2, and IL-17A. Generally, the anti-inflammatory outcomes resulted
by SM-LAB (except lipid peroxidation) were better as opposed to 8M-LABPC. Both
8M-LAB8 and SM-LABI2 also demonstrated their ability in significantly (p<0.05)
suppressing IBD associated genes, iNOS and NOD2 in the colitis mice model. In
conclusion, the results suggest that consumption of LAB strains is able to inhibit
several inflammatory markers and alleviates DC. Although LAB may offer as new
therapeutic option, further experiments must be conducted to understand the exact
mechanisms behind their action.
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